Difference between revisions of "WSI24-422-Case-3"

From MGH Learn Pathology
Line 37: Line 37:
 
|frames=4
 
|frames=4
 
|status=completed
 
|status=completed
 +
|reasonCode=H&E
 
|view=show
 
|view=show
 
|identifier=1db7c315-9721-429d-89dc-845624da02a3
 
|identifier=1db7c315-9721-429d-89dc-845624da02a3

Revision as of 14:00, February 3, 2026

WSI24-422-Case-3
34 yo F with invasive ductal carcinoma, s/p neoadjuvant therapy, extensive LVI
HER2 IHC: 2+

HER2 FISH: Not amplified

Ratio = 1.2, 3.2/2.5, Group 5
February 6, 2026 2:00:00 PM